A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia
NCT00154089
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Cervical Intraepithelial Neoplasia
Interventions
DRUG:
EM-1421
Sponsor
Erimos Pharmaceuticals
Collaborators
[object Object]
[object Object]